The global anatomic pathology market is estimated to be valued at US$ 34.75 billion in 2024 and is expected to exhibit a CAGR of 15% over the forecast period between 2024 to 2031.
The increasing adoption of precision medicine approaches for cancer treatment is a key driver augmenting market growth. Precision oncology relies on comprehensive genomic profiling of tumors to identify specific...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian